Condition: Inflammatory Bowel Disease (IBD) · Hepatitis B Virus · Sponsor: Tanta University
The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients. Researchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection. Participants will be subjected to history-taking (history of hospital admission and disease flare, surgical history, medication history, follow-up duration, and mortality), clinical examination, laboratory investigations, abdominal ultrasonography, and endoscopic examination.
This description comes directly from the study's public registry record.
Rania M Elkafoury, MD · +201004672358 · rania.elkafoury@med.tanta.edu.eg
Nabila A Elgazzar, MD · 00201288585733 · nabilaelgazzar@med.tanta.edu.eg
Always discuss trial participation with your own doctor first.
| Tanta University Hospitals | Tanta, Gharbyea, Egypt | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06881238